Keyword Searches the following fields: Name, SubName, 340B ID, Site ID, MPN, Grant Number, Address Line 1, Address Line 2, City. Grant/Provider Number Searches both Medicare Provider Number and Grant Number fields. Advanced Query Options Populates Start or Termination Date fields with quarterly dates.

The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. Manufacturers participating in Medicaid agree to provide outpatient drugs to covered entities at significantly reduced prices.

Contact the 340B Prime Vendor. You are entering an official US Government computer network! NEVER save your user-ID or password when accessing this system (especially on non-government computers). Please Note: You are entering an official United States government system, which may be used only for authorized purposes.

In calendar year 2023, 340B covered entities purchased $66.3 billion in covered outpatient drugs under the 340B Program. The program enables safety-net providers to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services for the communities that they serve.

We are required to collect information from manufacturers to verify the accuracy of 340B ceiling prices, and then make ceiling prices available to covered entities. We have developed a new, integrated information system that focuses on three key …

According to Health Resources and Services Administration (HRSA) data, total 340B drug sales in 2022—or the amount of money spent by all 340B covered entities purchasing drugs at the discounted 340B price—was $53.7 billion. 3 Of this amount, HRSA data show that 340B hospitals accounted for approximately $46.5 billion.

2024年10月24日 · The agency highlighted that under the 340B program, drug purchases at discounted 340B prices reached a record of $66.3 billion in 2023, representing a 24% year-over-year increase. These data allow stakeholders to better understand the size of the 340B program and its use by different covered entity types.

Under section 340B (a) of the Public Health Service Act (PHSA), the 340B ceiling price is calculated by subtracting the unit rebate amount (URA) from the average manufacturer price (AMP) for the smallest unit of measure of each covered outpatient drug (as identified by the product's 11-digit National Drug Code (NDC).

2025年3月18日 · 340B Drug Pricing Program Database. Home; Search. Search Covered Entities; Search Contract Pharmacies; Search Manufacturers; Reports; Help; Login; Reports 340B Office of Pharmacy Affairs Information System Public Site Reports. Medicaid Exclusion Files. Contract Pharmacy Carve-Ins.

2025年3月11日 · The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by Congress in 1992 designed the program to protect hospitals from rising drug costs — a dynamic that continues to present major challenges today. ... Data & Insights 340B Arrangements with Community and Specialty ...